| 國立臺灣大學 |
2008-03 |
Interleaving Phase Shifters for Critical-Mode Boost PFC
|
Tsai, J.-R.; Wu, T.-F.; Wu, C.-Y.; Lee, M.-C.; Chen, Y.-M. |
| 臺大學術典藏 |
2018-09-10T07:03:53Z |
Interleaving phase shifters for critical-mode boost PFC
|
Tsai, J.-R.; Wu, T.-F.; Wu, C.-Y.; Chen, Y.-M.; Lee, M.-C.; YAOW-MING CHEN |
| 大葉大學 |
2000-08 |
Interleaving Schemes for a Systolic RSA Public-Key Cryptosystem Based on an Improved Montgomery’s Algorithm
|
蔡培元;吳誠文 |
| 中國醫藥大學 |
2004 |
Interleukin (IL)-1 beta, IL-1 receptor antagonist, IL-6, IL-8, IL-10 and tumor necrosis factor alpha gene polymorphisms in patients with febrille seizures
|
Chou, IC; Tsai, CH; Lee, CC; Li, TC; Tsai, FJ; Yeh, TF |
| 中國醫藥大學 |
2010-05 |
Interleukin (IL)-1 β, IL-1 Receptor Antagonist, IL-6, IL-8, IL-10 and Tumor Necrosis Factor α Gene Polymorphisms in Patients with Febrile Seizures.
|
周宜卿(I-Ching Chou); 林瑋德(Wei-De Lin); 王仲興(Chung-Hsing Wang); 蔡長海(Chang-Hai Tsai); 李采娟(Tsai-Chung Li); 蔡輔仁(Fuu-Jen Tsai)* |
| 國立交通大學 |
2014-12-08T15:14:19Z |
Interleukin (IL)-12 receptor beta 1 codon 378 G homozygote and allele, but not IL-1 (beta-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3 '-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma
|
Hsieh, Yao-Yuan; Chang, Chi-Chen; Tsai, Chang-Hai; Lin, Cheng-Chieh; Tsai, Fuu-Jen |
| 亞洲大學 |
2007-04 |
Interleukin (IL)-12 receptor beta1 codon 378 G homozygote and allele, but not IL-1 (beta-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3'-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma
|
Hsieh Yao-Yuan;Chi-Chen Chang;Chang-Hai Tsai;Lin,Cheng-Chieh;Tsai,Fuu-Jen |
| 中國醫藥大學 |
2007-04 |
Interleukin (IL)-12 receptor β1 codon 378 G homozygote and allele, but not IL-1 (β-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3′-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma
|
謝耀元; (Chi-Chen Chang); 蔡長海; 林正介(Lin,Cheng-Chieh); 蔡輔仁(Tsai,Fuu-Jen)* |
| 大葉大學 |
2013-03 |
Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression
|
Sun, Ding-Ping;CH, Yeh;So, Edmund;Wang, Li-Yun;We, Tsui-Shan;Chang, Ming-Shi;Hsing, Chung-Hsi |
| 臺北醫學大學 |
2013 |
Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression
|
Sun, Ding-Ping;Yeh, Ching-Hua;So, Edmund;Wang, Li-Yun;Wei, Tsui-Shan;Chang, Ming-Shi;Hsing, Chung-Hsi |
| 臺北醫學大學 |
2013-06 |
Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression
|
邢中熹; Ding-Ping Sun, Ching-Hua Yeh, Edmund So, Li-Yun Wang, Tsui-Shan Wei, Ming-Shi Chang, Chung-Hsi Hsing |
| 臺北醫學大學 |
2013 |
Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression
|
Sun, Ding-Ping;Yeh, Ching-Hua;So, Edmund;Wang, Li-Yun;Wei, Tsui-Shan;Chang, Ming-Shi;Hsing, Chung-Hsi |
| 臺北醫學大學 |
2013 |
Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression
|
Sun, Ding-Ping;Yeh, Ching-Hua;So, Edmund;Wang, Li-Yun;Wei, Tsui-Shan;Chang, Ming-Shi;Hsing, Chung-Hsi |
| 國立成功大學 |
2013-06 |
Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression
|
Sun, Ding-Ping; Yeh, Ching-Hua; So, Edmund; Wang, Li-Yun; Wei, Tsui-Shan; Chang, Ming-Shi; Hsing, Chung-Hsi |
| 元培科技大學 |
2007 |
Interleukin (IL)-23 p19 expression induced by IL-1b in human fibroblast like synoviocytes with rheumatoid arthritis via active nuclear factor kappaB and AP-1 dependent pathway
|
Fei-Lan Liu;Jiun-Han Chen; Deh-Ming Chang |
| 元培科技大學 |
2007 |
Interleukin (IL)-23 p19 expression induced by IL-1b in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-iB and AP-1 dependent pathway
|
F-L Liu;C.-H. Chen;S.-J. Ch;J.-H. Chen; J.-H. Lai; H.-K. Sytwu; D.-M. Chang |
| 臺北醫學大學 |
2014 |
Interleukin 10 and clustering of metabolic syndrome components in pediatrics
|
JS, Chang;CH, Bai;ZC, Huang;Owaga, E;KC, Chao;CC, Chang;HY, Chiou |
| 高雄醫學大學 |
2006 |
Interleukin 12 A1188C frequency of gastric ulcer patients in Taiwan
|
鄭宇辰;吳登強;吳宜珍;溫政浩;張學偉 |
| 國立臺灣大學 |
1990 |
Interleukin 2 and Lymphokine Activated Cells in the Treatment of Childhood Primary Hepatocellular Carcinoma-a Preliminary Report
|
謝貴雄; Chang, J. S.; 吳慧琳; Chu, C. T.; Hsieh, Kue-Hsiung; Chang, J. S.; Wu, Hui-Lin; Chu, C. T. |
| 國立臺灣大學 |
1987 |
Interleukin 2 and Lymphokine-Activated Killer Cells in the Treatment of Childhood Primary Hepatocellular Carcinoma:A Preliminary Report
|
謝貴雄; Chang, J. S.; Wu, H. L.; Chu, C. T.; Hsieh, Kue-Hsiung; Chang, J. S.; Wu, H. L.; Chu, C. T. |
| 國立臺灣大學 |
1991 |
Interleukin 2 Therapy in Severe Atopic Dermatitis
|
謝貴雄; Chou, C. C.; Hsieh, Kue-Hsiung; Chou, C. C. |
| 臺大學術典藏 |
2021-08-19T10:23:39Z |
Interleukin 22 Expands Transit-Amplifying Cells While Depleting Lgr5 + Stem Cells via Inhibition of Wnt and Notch Signaling
|
Zha J.-M.; Li H.-S.; Lin Q.; WEI-TING KUO; Jiang Z.-H.; Tsai P.-Y.; Ding N.; Wu J.; Xu S.-F.; Wang Y.-T.; Pan J.; Zhou X.-M.; Chen K.; Tao M.; Odenwald M.A.; Tamura A.; Tsukita S.; Turner J.R.; He W.-Q. |
| 臺大學術典藏 |
2018-09-10T18:05:30Z |
Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease
|
Chin-Chung Shu and Jann-Yuan Wang and Ming-Fang Wu and Hsin-Chih Lai and Bor-Luen Chiang and Chong-Jen Yu; CHIN-CHUNG SHU; JANN-YUAN WANG |
| 臺大學術典藏 |
2018 |
Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease
|
Yu C.-J.; Chiang B.-L.; Lai H.-C.; Wu M.-F.; JANN-YUAN WANG; Shu C.-C. |
| 臺大學術典藏 |
2020-07-03T04:00:29Z |
Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease
|
Shu C.-C.;Wang J.-Y.;Wu M.-F.;Hsin-Chih Lai;Chiang B.-L.;Yu C.-J.; Shu C.-C.; Wang J.-Y.; Wu M.-F.; HSIN-CHIH LAI; Chiang B.-L.; Yu C.-J. |
| 臺大學術典藏 |
2021-06-29T08:39:13Z |
Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease
|
CHIN-CHUNG SHU; Wang J.-Y.; Wu M.-F.; Lai H.-C.; Chiang B.-L.; Yu C.-J. |
| 臺大學術典藏 |
2021-07-02T03:41:20Z |
Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease
|
Shu C.-C.; Wang J.-Y.; Wu M.-F.; Lai H.-C.; BOR-LUEN CHIANG; Yu C.-J. |
| 臺大學術典藏 |
2022-06-27T07:00:01Z |
Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease
|
Shu C.-C.; Wang J.-Y.; Wu M.-F.; Lai H.-C.; Chiang B.-L.; CHONG-JEN YU |
| 國家衛生研究院 |
2025-02-26 |
Interleukin 26 attenuates osteoblast differentiation in osteoarthritis patients by activating COX2 and NF-κB pathways
|
Lin, YH;Wang, YH;Peng, YJ;Liu, FC;Sytwu, HK;Cheng, CP |
| 國家衛生研究院 |
2023-04-19 |
Interleukin 26 induces macrophage IL-9 expression in rheumatoid arthritis
|
Wang, YH;Peng, YJ;Liu, FC;Lin, GJ;Huang, SH;Sytwu, HK;Cheng, CP |
| 國家衛生研究院 |
2020-04-10 |
Interleukin 26 skews macrophage polarization towards M1 phenotype by activating cJUN and the NF-kappaB pathway
|
Lin, YH;Wang, YH;Peng, YJ;Liu, FC;Lin, GJ;Huang, SH;Sytwu, HK;Cheng, CP |
| 國立臺灣大學 |
2012 |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Liu, Chen-Hua; Liang, Cheng-Chao; Liu, Chun-Jen; Tseng, Tai-Chung; Lin, Chih-Lin; Yang, Sheng-Shun; Su, Tung-Hung; Hsu, Shih-Jer; Lin, Jou-Wei; Chen, Jun-Herng; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 蘇東弘; 徐士哲; 劉俊人; 陳培哲; 陳俊恒; 林昭維 |
| 臺大學術典藏 |
2018-09-10T09:23:42Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Chen, Jun-Herng; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Chen, Jun-Herng; Lin, Jou-Wei; Lin, Jou-Wei; Hsu, Shih-Jer; Hsu, Shih-Jer; Su, Tung-Hung; Su, Tung-Hung; JIA-HORNG KAO; Lin, Chih-Lin; Yang, Sheng-Shun; Yang, Sheng-Shun; Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Tseng, Tai-Chung;Lin, Chih-Lin;Yang, Sheng-Shun;Su, Tung-Hung;Hsu, Shih-Jer;Lin, Jou-Wei;Chen, Jun-Herng;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, C.-H., Liang, C.-C., Liu, C.-J., Tseng, T.-C., Lin, C.-L., Yang, S.-S., Su, T.-H., Hsu, S.-J., Lin, J.-W., Chen, J.-H., Chen, P.-J., Chen, D.-S., Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;徐士哲 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;徐士哲 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; Liu, Chen-Hua; CHUN-JEN LIU; Liu, Chen-Hua; Liang, Cheng-Chao; PEI-JER CHEN; Liang, Cheng-Chao; Liu, Chun-Jen; Liu, Chun-Jen; CHEN-HUA LIU; Tseng, Tai-Chung; DING-SHINN CHEN; Tseng, Tai-Chung; Lin, Chih-Lin; TUNG-HUNG SU |
| 臺大學術典藏 |
2021-05-24T07:20:46Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
CHEN-HUA LIU; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:27Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:12:00Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:31:51Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:46Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 國立臺灣大學 |
2012 |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu, Chen-Hua; Liang, Cheng-Chao; Liu, Chun-Jen; Tseng, Tai-Chung; Lin, Chih-Lin; Yang, Sheng-Shun; Su, Tung-Hung; Lin, Jou-Wei; Chen, Jun-Herng; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人; 陳培哲; 陳俊恒; 林昭維 |
| 臺大學術典藏 |
2018-09-10T09:23:43Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Tseng, Tai-Chung;Lin, Chih-Lin;Yang, Sheng-Shun;Su, Tung-Hung;Lin, Jou-Wei;Chen, Jun-Herng;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, C.-H., Liang, C.-C., Liu, C.-J., Tseng, T.-C., Lin, C.-L., Yang, S.-S., Su, T.-H., Lin, J.-W., Chen, J.-H., Chen, P.-J., Chen, D.-S., Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; Liu, Chen-Hua; Liu, Chen-Hua; CHUN-JEN LIU; Liang, Cheng-Chao; Liang, Cheng-Chao; PEI-JER CHEN; CHEN-HUA LIU; Liu, Chun-Jen; DING-SHINN CHEN; Tseng, Tai-Chung; TUNG-HUNG SU; Lin, Chih-Lin; Yang, Sheng-Shun; JIA-HORNG KAO; Su, Tung-Hung; Lin, Jou-Wei; Lin, Jou-Wei; Chen, Jun-Herng; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2021-05-24T07:20:46Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
CHEN-HUA LIU; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:28Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:51Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:46Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:12:00Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 國立臺灣大學 |
2010 |
Interleukin 4 and Stat6 Gene Polymorphisms Are Associated with Systemic Lupus Erythematosus in Chinese Patients
|
俞欣慧; 劉碧華; 陳為堅; 李志鴻; 王麗潔; 楊曜旭; 江伯倫; YU, HSIN-HUI; LIU, PI-HUA; CHEN, WEI-JANE; LEE, JYH-HONG; WANG, LI-CHIEH; YANG, YAO-HSU; CHIANG, BOR-LUEN |
| 臺大學術典藏 |
2020-12-08T08:20:26Z |
Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients
|
Yu H.-H.;Liu P.-H.;Lin Y.-C.;Chen W.J.;Jyh-Hong Lee;Wang L.-C.;Yang Y.-H.;Chiang B.-L.; Yu H.-H.; Liu P.-H.; Lin Y.-C.; Chen W.J.; JYH-HONG LEE; Wang L.-C.; Yang Y.-H.; Chiang B.-L. |
| 臺大學術典藏 |
2021-01-06T08:23:42Z |
Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients
|
Yu H.-H.;Liu P.-H.;Lin Y.-C.;Chen W.J.;Lee J.-H.;Wang L.-C.;Yao-Hsu Yang;Chiang B.-L.; Yu H.-H.; Liu P.-H.; Lin Y.-C.; Chen W.J.; Lee J.-H.; Wang L.-C.; YAO-HSU YANG; Chiang B.-L. |
| 臺大學術典藏 |
2021-07-02T03:41:57Z |
Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients
|
Yu H.-H.; Liu P.-H.; Lin Y.-C.; Chen W.J.; Lee J.-H.; Wang L.-C.; Yang Y.-H.; BOR-LUEN CHIANG |
| 臺大學術典藏 |
2022-05-05T05:16:09Z |
Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients
|
Yu H.-H.; Liu P.-H.; Lin Y.-C.; WEI J. CHEN; Lee J.-H.; Wang L.-C.; Yang Y.-H.; Chiang B.-L. |
